Inventor · disambiguated record
Hyuk Sang Kwon
Also filed as: KWON HYUK · KWON HYUK-SANG
10 granted patents·2 pending applications·114 citations·filing 1996–2024
87Inventor score
Files withEMAGIN CORP4IL DONG PHARMA3ILDONG PHARM CO LTD2MASSACHUSETTS INST TECHNOLOGY1SAMSUNG ELECTRONICS CO LTD1
Top patents by PatentIndex Score
12 records- 0191US11955072B2OLED-based display having pixel compensation and methodEMAGIN CORP·Filed 2022·Granted Apr 9, 2024·2 cites·8 claims
- 0289US11738064B2Pharmaceutical composition for preventing and treating eye diseases, containing as active ingredient, fusion protein in which tissue-penetrating peptide and anti-vascular endothelial growth factor preparation are fusedILDONG PHARM CO LTD·Filed 2021·Granted Aug 29, 2023·2 cites·9 claims
- 0382US11052130B2Method for treating eye diseases with a fusion protein of a tissue-penetrating peptide and anti-vascular endothelial growth factorILDONG PHARM CO LTD·Filed 2017·Granted Jul 6, 2021·2 cites·5 claims
- 0480US6255642B1Standing wave total internal reflection imagingMASSACHUSETTS INST TECHNOLOGY·Filed 1999·Granted Jul 3, 2001·63 cites·21 claims
- 0572US12217668B2OLED-based display having pixel compensation and methodEMAGIN CORP·Filed 2024·Granted Feb 4, 2025·0 cites·9 claims
- 0672US10919947B2Pharmaceutical composition containing, as active ingredient, fusion protein in which tumor-penetrating peptide and anti-angiogenesis agent are fused, for preventing and treating cancer or angiogenesis-related diseasesIL DONG PHARMA·Filed 2018·Granted Feb 16, 2021·1 cites·10 claims
- 0760US5959915ATest method of integrated circuit devices by using a dual edge clock techniqueSAMSUNG ELECTRONICS CO LTD·Filed 1998·Granted Sep 28, 1999·25 cites·20 claims
- 0855US5721740AFlip-flop controller for selectively disabling clock signalSAMSUNG ELECTRONOCS CO LTD·Filed 1996·Granted Feb 24, 1998·19 cites·3 claims
- 0954US11862095B2OLED-based display having pixel compensation and methodEMAGIN CORP·Filed 2022·Granted Jan 2, 2024·0 cites·15 claims
- 1051US2022409677A1Novel probiotic composition for regulation of intestinal immunityIL DONG PHARMA·Filed 2019·Application pending·0 cites
- 1151US2021253657A1Pharmaceutical composition containing, as active ingredient, fusion protein in which tumor-penetrating peptide and antiangiogenesis agent are fused, for preventing and treating cancer or angiogenesis-related diseasesIL DONG PHARMA·Filed 2021·Application pending·0 cites
- 1234US10741129B2Reconfigurable display and method thereforEMAGIN CORP·Filed 2017·Granted Aug 11, 2020·0 cites·14 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →